A One Health approach to antimicrobial resistance surveillance: is there a business case for it?

A One Health approach to antimicrobial resistance surveillance: is there a business case for it?

Highlights • Antimicrobial resistance surveillance requires an integrated One Health approach. • A conceptual framework for a One Health approach to surveillance is presented. • Current surveillance systems (from local to global) fall short of this framework. • Policy decisions favour economic evide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of antimicrobial agents 2016-10, Vol.48 (4), p.422-427
Hauptverfasser: Queenan, Kevin, Häsler, Barbara, Rushton, Jonathan
Format: Artikel
Sprache:eng
Schlagworte:
AMR
Animals
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antimicrobial resistance
Business case
Cost-Benefit Analysis
Drug Resistance, Bacterial
Drug Utilization
Economics
Epidemiological Monitoring
Global Health
Humans
Infectious Disease
One Health
Surveillance
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Antimicrobial resistance surveillance requires an integrated One Health approach. • A conceptual framework for a One Health approach to surveillance is presented. • Current surveillance systems (from local to global) fall short of this framework. • Policy decisions favour economic evidence, so a business case is proposed. • Broad benefits to society, animal welfare, ecosystem health and more are included.
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2016.06.014